Oct 23 (Reuters) - Adocia SA ADOC.PA :
* ADOCIA’S PARTNER TONGHUA DONGBAO ANNOUNCES POSITIVE
RESULTS OF
THREE CLINICAL TRIALS ON BIOCHAPERONE® COMBO
* DATA GENERATED ON THREE STUDIES WILL BE SUBMITTED TO CDE
AND
USED TO SUPPORT APPLICATION TO ENTER NEXT CLINICAL DEVELOPMENT
PHASE
* THREE CLINICAL TRIALS ON BIOCHAPERONE COMBO WERE CONDUCTED
IN
GERMANY ON SUBJECTS WITH TYPE 1 DIABETES, TYPE 2 DIABETES AND ON
HEALTHY VOLUNTEERS WITH CHINESE ORIGIN
* OVERALL ASSESSMENT SHOWED THAT BC COMBO HAD A GOOD
BENEFIT/RISK
RATIO, SUPPORTING ITS CLINICAL DEVELOPMENT INTO NEXT PHASE
Source text for Eikon: ID:nBw1SnMV7a
Further company coverage: ADOC.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))